Maternal angiogenic profile in pregnancies that remain normotensive

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 158, Issue 2, 2011, Pages 189-193

  Faupel Badger, Jessica M ^a   Staff, Anne Cathrine ^b,c   Thadhani, Ravi ^d   Powe, Camille E ^d   Potischman, Nancy ^a   Hoover, Robert N ^a   Troisi, Rebecca ^a,e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Angiogenic factors; Maternal; PlGF; Pregnancy; sFlt1; Soluble endoglin

Indexed keywords

ENDOGLIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GROWTH FACTOR; PLACENTAL LIKE GROWTH FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CONTROLLED CLINICAL TRIAL; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MATERNAL AGE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; NULLIPARA; PARITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; SYSTOLIC BLOOD PRESSURE;

EID: 80053561895     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2011.05.001     Document Type: Article

References (25)

1. P. Kaufmann, T.M. Mayhew, and D.S. Charnock-Jones Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy Placenta 25 2-3 2004 114 126 (Pubitemid 38248056)
2. J.A. Arroyo, and V.D. Winn Vasculogenesis and angiogenesis in the IUGR placenta Semin Perinatol 32 3 2008 172 177 (Pubitemid 351636324)
3. B.C. Young, R.J. Levine, and Karumanchi SA Pathogenesis of preeclampsia Annu Rev Pathol 5 2010 173 192
4. R.J. Levine, C. Lam, and C. Qian Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 10 2006 992 1005 (Pubitemid 44343543)
5. R.J. Levine, S.E. Maynard, and C. Qian Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 7 2004 672 683 (Pubitemid 38364626)
6. R.J. Levine, C. Qian, S.E. Maynard, K.F. Yu, F.H. Epstein, and S.A. Karumanchi Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women Am J Obstet Gynecol 194 4 2006 1034 1041
7. S.E. Maynard, J.Y. Min, and J. Merchan Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 5 2003 649 658 (Pubitemid 36278583)
8. S. Rana, S.A. Karumanchi, and R.J. Levine Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia Hypertension 50 1 2007 137 142 (Pubitemid 46986022)
9. R. Romero, J.K. Nien, and J. Espinoza A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate J Matern Fetal Neonatal Med 21 1 2008 9 23
10. A.C. Staff, K. Braekke, N.K. Harsem, T. Lyberg, and M.R. Holthe Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia Eur J Obstet Gynecol Reprod Biol 122 1 2005 33 39 (Pubitemid 41265677)
11. R. Thadhani, W.P. Mutter, and M. Wolf First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia J Clin Endocrinol Metab 89 2 2004 770 775 (Pubitemid 38269892)
12. S. Venkatesha, M. Toporsian, and C. Lam Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 6 2006 642 649 (Pubitemid 43865232)
13. W.P. Mutter, and S.A. Karumanchi Molecular mechanisms of preeclampsia Microvasc Res 75 1 2008 1 8 (Pubitemid 350266733)
14. R. Troisi, K. Braekke, N.K. Harsem, M. Hyer, R.N. Hoover, and A.C. Staff Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies Am J Obstet Gynecol 199 6 2008 653 e1-10
15. A.C. Staff, N.K. Harsem, K. Braekke, M. Hyer, R.N. Hoover, and R. Troisi Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies Eur J Obstet Gynecol Reprod Biol 143 1 2009 29 33
16. R. Thadhani, J.L. Ecker, E. Kettyle, L. Sandler, and F.D. Frigoletto Pulse pressure and risk of preeclampsia: a prospective study Obstet Gynecol 97 4 2001 515 520
17. M. Wolf, A. Shah, and C. Lam Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies Am J Obstet Gynecol 193 1 2005 16 22 (Pubitemid 40991821)
18. G.A. Dekker Risk factors for preeclampsia Clin Obstet Gynecol 42 3 1999 422 435 (Pubitemid 30017267)
19. R. Thadhani, M.J. Stampfer, D.J. Hunter, J.E. Manson, C.G. Solomon, and G.C. Curhan High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy Obstet Gynecol 94 4 1999 543 550 (Pubitemid 29460937)
20. M. Wolf, A. Shah, R. Jimenez-Kimble, J. Sauk, J.L. Ecker, and R. Thadhani Differential risk of hypertensive disorders of pregnancy among Hispanic women J Am Soc Nephrol 15 5 2004 1330 1338 (Pubitemid 38526015)
21. R.S. Mijal, C.B. Holzman, S. Rana, S.A. Karumanchi, J. Wang, and A. Sikorskii Midpregnancy levels of angiogenic markers in relation to maternal characteristics Am J Obstet Gynecol 204 3 2011 244.e1 244.e12
22. R. Mehendale, J. Hibbard, A. Fazleabas, and R. Leach Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke Am J Obstet Gynecol 197 4 2007 363 e1-5
23. A. Jeyabalan, R.W. Powers, A.R. Durica, G.F. Harger, J.M. Roberts, and R.B. Ness Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia Am J Hypertens 21 8 2008 943 947
24. S.A. Karumanchi, and R.J. Levine How does smoking reduce the risk of preeclampsia? Hypertension 55 5 2010 1100 1101
25. R. Troisi, N. Potischman, J. Roberts, P. Siiteri, A. Daftary, C. Sims, and R.N. Hoover Associations of maternal and umbilical cord hormone concentrations with maternal, gestational and neonatal factors (United States) Cancer Causes Control 14 4 2003 347 355 (Pubitemid 36735104)